[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)
date : 2/22/2022
Tags: AMR
![[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-case05_ENG-top.jpg)
As part of the Alliance’s project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Dr. Keisuke Kagami (Department of Pharmacy, Hokkaido University Hospital) and Dr. Mitsuru Sugawara (Department of Pharmacy, Hokkaido University Hospital / Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University) reports a case titled “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.”
In this study, the usefulness of TDM (Therapeutic Drug Monitoring) for antimicrobial stewardship is reported.
Case study 05
Dr. Keisuke Kagami (Department of Pharmacy, Hokkaido University Hospital)
Dr. Mitsuru Sugawara (Department of Pharmacy, Hokkaido University Hospital / Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University)
“Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
Case study 04
Dr. Akari Shigemi (Division of Pharmacy / Department of Infection Control and Prevention, Kagoshima University Hospital)
“The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance”
![[AMR Case Study 04] Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury](/assets/img/katsudo/icon_pdf_l.png){kind=icon}
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
![[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_eyecatch_20260619_AMR_Recommendations.png)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
![[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_2nd_eyecatch_web.jpg)
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
![[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260722_PLH-Academy-2.png)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
![[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/ckd-ncd-20260731-top_ENG.png)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
![[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260930_The4th-J-PEPseminar.jpg)
